News on 90-day Phase2 results due soon...If current CR and PR levels are improved, we're in for a breakthrough designation (BTD) from the FDA.
If they remain even, we still have the cure for cancer here, since the Phase2 testing protocol calls for a maximum of two treatments, but in real life, you can treat until CR is achieved.
In fact, 3-4 treatments for some patients (remember, 2 in Phase1 had a durable CR after only one treatment!) will only mean more money for TLT!
So, it's a no-fail, win-win scenario here...
My favourite kind!
GLTA!